{"id":"https://openalex.org/W2052657792","doi":"https://doi.org/10.1212/wnl.53.9.2010","title":"Metrifonate treatment of AD: Influence of APOE genotype","display_name":"Metrifonate treatment of AD: Influence of APOE genotype","alternate_titles":[],"publication_year":1999,"publication_date":"1999-12-01","ids":{"openalex":"https://openalex.org/W2052657792","doi":"https://doi.org/10.1212/wnl.53.9.2010","mag":"2052657792","pmid":"https://pubmed.ncbi.nlm.nih.gov/10599773"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.53.9.2010","doi":"https://doi.org/10.1212/wnl.53.9.2010","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.53.9.2010","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2052657792"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071364728","display_name":"Martin Rhys Farlow","orcid":"https://orcid.org/0000-0001-7897-5471","observed_orcids":["https://orcid.org/0000-0001-7897-5471"]},"institutions":[{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M.R. Farlow","raw_affiliation_strings":["From the Indiana University School of Medicine (Drs. FarlowLahiri, and Brashear), Indianapolis, IN; and Bayer Corporation (Drs. Cyrus, Nadel, and Gulanski), West Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Indiana University School of Medicine (Drs. FarlowLahiri, and Brashear), Indianapolis, IN; and Bayer Corporation (Drs. Cyrus, Nadel, and Gulanski), West Haven, CT","institution_ids":["https://openalex.org/I4394709130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111679623","display_name":"P. Cyrus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P.A. Cyrus","raw_affiliation_strings":["From the Indiana University School of Medicine (Drs. FarlowLahiri, and Brashear), Indianapolis, IN; and Bayer Corporation (Drs. Cyrus, Nadel, and Gulanski), West Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Indiana University School of Medicine (Drs. FarlowLahiri, and Brashear), Indianapolis, IN; and Bayer Corporation (Drs. Cyrus, Nadel, and Gulanski), West Haven, CT","institution_ids":["https://openalex.org/I4394709130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048908223","display_name":"Andrea Nadel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Nadel","raw_affiliation_strings":["From the Indiana University School of Medicine (Drs. FarlowLahiri, and Brashear), Indianapolis, IN; and Bayer Corporation (Drs. Cyrus, Nadel, and Gulanski), West Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Indiana University School of Medicine (Drs. FarlowLahiri, and Brashear), Indianapolis, IN; and Bayer Corporation (Drs. Cyrus, Nadel, and Gulanski), West Haven, CT","institution_ids":["https://openalex.org/I4394709130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083481724","display_name":"Debomoy K. Lahiri","orcid":"https://orcid.org/0000-0002-1664-5933","observed_orcids":["https://orcid.org/0000-0002-1664-5933"]},"institutions":[{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D.K. Lahiri","raw_affiliation_strings":["From the Indiana University School of Medicine (Drs. FarlowLahiri, and Brashear), Indianapolis, IN; and Bayer Corporation (Drs. Cyrus, Nadel, and Gulanski), West Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Indiana University School of Medicine (Drs. FarlowLahiri, and Brashear), Indianapolis, IN; and Bayer Corporation (Drs. Cyrus, Nadel, and Gulanski), West Haven, CT","institution_ids":["https://openalex.org/I4394709130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070982600","display_name":"Allison Brashear","orcid":"https://orcid.org/0000-0002-8812-7545","observed_orcids":["https://orcid.org/0000-0002-8812-7545"]},"institutions":[{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Brashear","raw_affiliation_strings":["From the Indiana University School of Medicine (Drs. FarlowLahiri, and Brashear), Indianapolis, IN; and Bayer Corporation (Drs. Cyrus, Nadel, and Gulanski), West Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Indiana University School of Medicine (Drs. FarlowLahiri, and Brashear), Indianapolis, IN; and Bayer Corporation (Drs. Cyrus, Nadel, and Gulanski), West Haven, CT","institution_ids":["https://openalex.org/I4394709130"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070251180","display_name":"Barbara Gulanski","orcid":"https://orcid.org/0000-0003-4056-3409","observed_orcids":["https://orcid.org/0000-0003-4056-3409"]},"institutions":[{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"B. Gulanski","raw_affiliation_strings":["From the Indiana University School of Medicine (Drs. FarlowLahiri, and Brashear), Indianapolis, IN; and Bayer Corporation (Drs. Cyrus, Nadel, and Gulanski), West Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Indiana University School of Medicine (Drs. FarlowLahiri, and Brashear), Indianapolis, IN; and Bayer Corporation (Drs. Cyrus, Nadel, and Gulanski), West Haven, CT","institution_ids":["https://openalex.org/I4394709130"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4394709130"],"apc_list":null,"apc_paid":null,"fwci":1.7903,"has_fulltext":false,"cited_by_count":58,"citation_normalized_percentile":{"value":0.84346088,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":95},"biblio":{"volume":"53","issue":"9","first_page":"2010","last_page":"2010"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.5776000022888184,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.5776000022888184,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.38960000872612,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.02930000051856041,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trichlorfon","display_name":"trichlorfon","score":0.9850000143051147},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9319999814033508},{"id":"https://openalex.org/keywords/apoe-genotype","display_name":"APOE genotype","score":0.984000027179718},{"id":"https://openalex.org/keywords/acetylcholinesterase-inhibitors","display_name":"acetylcholinesterase inhibitors","score":0.9549999833106995},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.6700000166893005},{"id":"https://openalex.org/keywords/genetic-interactions","display_name":"genetic interactions","score":0.5270000100135803},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.8659999966621399},{"id":"https://openalex.org/keywords/cognitive-performance","display_name":"cognitive performance","score":0.9269999861717224},{"id":"https://openalex.org/keywords/global-function","display_name":"global function","score":0.5920000076293945},{"id":"https://openalex.org/keywords/biomarker-prediction","display_name":"biomarker prediction","score":0.39899998903274536}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49020010232925415},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.35378938913345337}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D001057","descriptor_name":"Apolipoproteins E","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014236","descriptor_name":"Trichlorfon","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014236","descriptor_name":"Trichlorfon","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1212/wnl.53.9.2010","doi":"https://doi.org/10.1212/wnl.53.9.2010","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.53.9.2010","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},{"id":"pmid:10599773","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10599773","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W1847168837","https://openalex.org/W1953027527","https://openalex.org/W1966030100","https://openalex.org/W1968892572","https://openalex.org/W1972340735","https://openalex.org/W1982064952","https://openalex.org/W1982745715","https://openalex.org/W1985137206","https://openalex.org/W1986539898","https://openalex.org/W1997671619","https://openalex.org/W1999631936","https://openalex.org/W2004883238","https://openalex.org/W2016659621","https://openalex.org/W2017231145","https://openalex.org/W2023054003","https://openalex.org/W2026267640","https://openalex.org/W2034968148","https://openalex.org/W2035236207","https://openalex.org/W2036362108","https://openalex.org/W2036736649","https://openalex.org/W2041394188","https://openalex.org/W2046366626","https://openalex.org/W2052243021","https://openalex.org/W2052261143","https://openalex.org/W2069284334","https://openalex.org/W2072150523","https://openalex.org/W2076228346","https://openalex.org/W2086363884","https://openalex.org/W2111774300","https://openalex.org/W2117180000","https://openalex.org/W2119062449","https://openalex.org/W2130992306","https://openalex.org/W2137103253","https://openalex.org/W2156220037","https://openalex.org/W2162786843","https://openalex.org/W2282488325","https://openalex.org/W2503214490"],"related_works":["https://openalex.org/W2067162295","https://openalex.org/W2023054003","https://openalex.org/W2036736649","https://openalex.org/W2016659621","https://openalex.org/W1980479088","https://openalex.org/W2087883935","https://openalex.org/W1602442700","https://openalex.org/W2885014944","https://openalex.org/W2069284334","https://openalex.org/W2095894225"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"investigate":[2],"whether":[3,20],"an":[4,247,265],"interaction":[5,121,166,248],"exists":[6],"between":[7,249],"APOE":[8,21,94,123,168,191,207,250,259,274],"genotype":[9,22,124,169,208,251,275],"and":[10,19,55,125,194,252,272],"the":[11,25,38,100,104,126,142,146,171,279],"response":[12,195,268],"of":[13,27,40,60,103,122,145,156,167,237,281],"AD":[14,28,41,105,147,266],"patients":[15,62,106,148,285],"to":[16,73,89,93,196,239,269,288],"metrifonate":[17,71,127,172,197,253,270],"treatment":[18,39,198,254,271],"independently":[23],"affects":[24],"rate":[26,280],"progression.":[29],"BACKGROUND:":[30],"Metrifonate":[31,97,138],"is":[32],"a":[33,80],"new":[34],"acetylcholinesterase":[35],"inhibitor":[36],"for":[37,87,284],"symptoms.":[42],"METHODS:":[43],"Data":[44],"were":[45,132,188],"pooled":[46],"from":[47,234],"four":[48],"prospective,":[49],"randomized,":[50],"double-blind,":[51],"placebo-controlled":[52],"clinical":[53],"trials":[54],"analyzed":[56],"retrospectively.":[57],"A":[58],"total":[59],"959":[61],"who":[63],"received":[64],"once-daily":[65],"placebo":[66,110,152],"(n":[67],"=":[68,85,118,136,163,182,201,205,222,229],"374)":[69],"or":[70,79,224],"(30":[72],"60":[74],"mg":[75],"based":[76],"on":[77,129,174],"weight":[78],"50-mg":[81],"fixed":[82],"dose,":[83],"n":[84],"585)":[86],"up":[88,238],"26":[90,240],"weeks":[91],"agreed":[92],"genotyping.":[95],"RESULTS:":[96],"clearly":[98,140,245],"improved":[99,141],"cognitive":[101,130,218],"performance":[102,131,219],"when":[107,149],"compared":[108,150],"with":[109,151,158,170,286],"(Alzheimer's":[111],"Disease":[112],"Assessment":[113],"Scale-Cognitive":[114],"Subscale":[115],"[ADAS-Cog],":[116],"p":[117,162,200,204,221,228],"0.0001).":[119,164],"The":[120,165,232],"effect":[128,173],"not":[133,179,210,244,262,277],"significant":[134,180,185],"(p":[135,181],"0.25).":[137],"also":[139,177],"global":[143,175,225],"function":[144,176,226],"(Clinician's":[153],"Interview-Based":[154],"Impression":[155],"Change":[157],"Caregiver":[159],"Input":[160],"[CIBIC-Plus],":[161],"was":[178],"0.70).":[183],"No":[184],"three-way":[186],"interactions":[187],"observed":[189],"among":[190],"genotype,":[192],"gender,":[193],"(ADAS-Cog,":[199,220],"0.68;":[202],"CIBIC-Plus,":[203],"0.26).":[206],"did":[209],"influence":[211,278],"disease":[212,282],"progression":[213,283],"as":[214],"evaluated":[215],"by":[216],"either":[217],"0.93)":[223],"(CIBIC-Plus,":[227],"0.64).":[230],"CONCLUSIONS:":[231],"findings":[233],"these":[235],"studies":[236],"weeks'":[241],"duration":[242],"do":[243,261],"support":[246],"effects.":[255],"They":[256],"suggest":[257],"that":[258,273],"genotypes":[260],"necessarily":[263],"predict":[264],"patient's":[267],"may":[276],"mild":[287],"moderate":[289],"AD.":[290]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2052657792","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
